Pharmaceuticals, Biotechnology and Life Sciences
FOSTER CITY, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) — TrueBinding, Inc., a clinical-stage biotherapeutics company focused on pioneering the development…
– Met primary endpoint with LDL-C mean reduction versus placebo of 36.3% at day 84 and 41.5% at day 365…
Accomplished biotechnology CEO brings 25 years of strategic, operational, and legal experienceFOSTER CITY, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) —…
PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first “Phagogram Day” This event, organized in…
Ben Austin, SPR Therapeutics Ben Austin, Chief Financial Officer and Chief Operating Officer of SPR Therapeutics. CLEVELAND, Nov. 18, 2024…
– Acoramidis demonstrated the earliest known time to separation in cardiovascular outcomes in the ATTRibute-CM study (3 months), with statistically…
SAN FRANCISCO, Nov. 18, 2024 (GLOBE NEWSWIRE) — Siren Biotechnology, pioneer of AAV immuno-gene therapy for cancer, today revealed its…
Data demonstrate potential superiority of a targeted protein degradation strategy compared to kinase inhibition for both BTK and IRAK4 targets…
Consistently rapid, deep and durable reduction in serum TTR accompanied by evidence of disease stabilization or improvement after a one-time…
SHANGHAI, Nov. 16, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…